WEDNESDAY, Dec. 14, 2022 (HealthDay News) — Almost 15 million people likely died as a result of the COVID-19 pandemic in 2020 and 2021, nearly three times more than previously reported, a new World Health Organization study estimates. The researchers said the COVID-19 pandemic caused about 4.5 million more deathsContinue Reading

WEDNESDAY, Dec. 14, 2022 (HealthDay News) — For some people, dozens of U.S.-approved drugs can lead to a rare but often fatal brain infection. Researchers have now confirmed a strong link between four genetic mutations and this illness, called progressive multifocal leukoencephalopathy (PML). A new study found that in peopleContinue Reading

MONDAY, Dec. 12, 2022 (HealthDay News) – As three highly contagious respiratory viruses spread across the United States, straining hospitals and triggering drug shortages, health officials in some major cities and states are calling for a return to indoor masking. Over the past few weeks, COVID-19, the flu and RSVContinue Reading

MONDAY, Dec. 5, 2022 (HealthDay News) — Flu, RSV and COVID-19 are creating a perfect storm of respiratory disease that is overwhelming the nation’s health care systems. Vaccination will be key to getting through the winter holidays with your health intact, U.S. Centers for Disease Control and Prevention Director Dr.Continue Reading

MONDAY, Dec. 5, 2022 (HealthDay News) – The Laundress, a laundry and cleaning products company, has recalled nearly 8 million of its products over concerns they may be contaminated with various bacteria. The bacteria include Burkholderia cepacia complex, Klebsiella aerogenes and multiple different species of Pseudomonas. So far, testing hasContinue Reading

THURSDAY, Dec. 1, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Wednesday approved the first fecal microbiota treatment, aimed at helping adults battling tough-to-treat Clostridium difficile (C. diff) infections. “Today’s approval of Rebyota is an advance in caring for patients who have recurrent C. difficile infection [CDI],”Continue Reading

WEDNESDAY, Nov. 30, 2022 (HealthDay News) — An early surge in cold and flu cases has created shortages in key antiviral and antibiotic drugs needed for the annual “sick season,” pharmacists report. The antiviral flu drug Tamiflu is in short supply for both adults and children, in both its brandContinue Reading